Nektar Therapeutics (NKTR) Interest & Investment Income (2023 - 2025)
Historic Interest & Investment Income for Nektar Therapeutics (NKTR) over the last 8 years, with Q3 2025 value amounting to $2.8 million.
- Nektar Therapeutics' Interest & Investment Income fell 1798.08% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.6 million, marking a year-over-year decrease of 3444.2%. This contributed to the annual value of $14.5 million for FY2024, which is 2372.03% down from last year.
- Per Nektar Therapeutics' latest filing, its Interest & Investment Income stood at $2.8 million for Q3 2025, which was down 1798.08% from $2.0 million recorded in Q2 2025.
- In the past 5 years, Nektar Therapeutics' Interest & Investment Income ranged from a high of $5.2 million in Q3 2023 and a low of $2.0 million during Q2 2025
- In the last 3 years, Nektar Therapeutics' Interest & Investment Income had a median value of $3.9 million in 2024 and averaged $3.7 million.
- As far as peak fluctuations go, Nektar Therapeutics' Interest & Investment Income tumbled by 265.28% in 2024, and later plummeted by 4952.58% in 2025.
- Over the past 3 years, Nektar Therapeutics' Interest & Investment Income (Quarter) stood at $4.6 million in 2023, then crashed by 36.28% to $2.9 million in 2024, then decreased by 4.18% to $2.8 million in 2025.
- Its Interest & Investment Income stands at $2.8 million for Q3 2025, versus $2.0 million for Q2 2025 and $2.9 million for Q1 2025.